1
Clinical Trials associated with GSK-971086A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK971086 After a Single Dose and 7 Days of Repeat Dosing in Healthy Adult Male Volunteers
This research study is the first administration of GSK971086 in humans. The purpose of this study is to assess the safety and tolerability of GSK971086, as well as, how much GSK971086 is in your blood after different doses
100 Clinical Results associated with GSK-971086
100 Translational Medicine associated with GSK-971086
100 Patents (Medical) associated with GSK-971086
100 Deals associated with GSK-971086